Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Melanoma etiology: where are we?

Oncogene volume 22, pages 3042–3052 (2003)Cite this article

Abstract

Melanoma incidence rates are rising rapidly, particularly in older men. Older men are also more likely to have thick melanomas, which confer high mortality and morbidity. The reasons for the rate of increase are not known; increasing sun and UV exposure, however, is the major hypothesized explanation. In the past several years, two major susceptibility genes for melanoma, CDKN2A and CDK4, have been identified, but the two genes together account for a minority of familial melanoma. Other high-risk susceptibility genes are being sought actively. Genetic epidemiologic studies suggest that penetrance of each of the two identified genes is altered by other factors, either genetic or environmental. Epidemiologic studies have also identified other major host factors important in the development of melanoma. In European, North American, and Australian populations, the presence of clinically identified dysplastic nevi confers greatly increased risk of melanoma. A new measure of sun exposure, based on individual residential history, confers substantially increased risk of melanoma. Recent surveys of sun behavior in the US reveal extensive sunburning and use of tanning beds in adolescents and adults. Sun protective behaviors are not as prevalent as in Australia, where population rates of melanoma are stabilizing.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Aitken JF, Duffy DL, Green A, Youl P, MacLennan R and Martin NG . (1994). Am. J. Epidemiol., 140, 961–973.

  • Aitken J, Welch J, Duffy D, Milligan A, Green A, Martin N and Hayward N . (1999). J. Natl. Cancer Inst., 91, 446–452.

  • American Society of Clinical Oncology. (1996). J. Clin. Oncol., 14, 1730–1740.

  • Ang CG, Kelly JW, Fritschi L and Dowling JP . (1998). Melanoma Res., 8, 459–464.

  • Armstrong BK and Kricker A . (2001). J. Photochem. Photobiol. B:Biol., 63, 8–18.

  • Augustsson A, Stierner U, Rosdahl I and Suurkula M . (1990). Acta Derm. Venereol. (Stockh.), 71, 518–524.

  • Auroy S, Avril M-F, Chompret A, Pham D, Goldstein AM, Bianchi-Scarrà G, Frebourg T, Joly P, Spatz A, Rubino C, Demenais F, French Hereditary Melanoma Study Group and Bressac-de Paillerets B . (2001). Genes, Chromosomes & Cancer, 32, 195–202.

  • Bale SJ, Chakravarti A and Greene MH . (1986). Am. J. Hum. Genet., 38, 188–196.

  • Barnhill RL, Rousch GC and Titus-Ernstoff L . (1992). Dermatology, 184, 2–7.

  • Bastuji-Garin S and Diepgen TL . (2002). Br. J. Dermatol., 146(Suppl. 61), 24–30.

  • Bataille V, Snieder H, MacGregor AJ, Sasieni P and Spector TD . (2000). J. Natl. Cancer Inst., 92, 457–463.

  • Bataille V, Grulich A, Sasieni P, Swerdlow A, Newton-Bishop J, McCarthy W, Hersey P and Cuzick J . (1998). Br. J. Cancer, 77, 505–510.

  • Beral V, Evans S, Shaw H and Milton G . (1977). Br. J. Cancer, 50, 681–685.

  • Bergenmar M and Brandberg Y . (2001). Cancer Nursing, 24, 341–350.

  • Bergman W, Gruis N and Frants RR . (1992). Cytogenet. Cell Genet., 59, 161–164.

  • Bishop DT, Demenais F, Goldstein AM, Bergman W, Newton Bishop J, Bressac-de Paillerets B, Chompret A, Ghiorzo P, Gruis N, Hansson J, Harland M, Hayward N, Holland EA, Mann GJ, Mantelli M, Nancarrow D, Platz A, Tucker MA and the Melanoma Genetics Consortium. (2002). J. Natl. Cancer Inst., 94, 894–903.

  • Bliss JM, Ford D, Swerdlow AJ, Armstrong BK, Cristofolini M, Elwood JM, Green A, Holly EA, Mack T, MacKie RM, Osterlind A, Walter SD, Peto J and Easton DF . (1995). Int. J. Cancer, 62, 367–376.

  • Borg A, Johannsson U, Johannsson O, Hakansson S, Westerdahl J, Masback A, Olsson H and Ingvar C . (1996). Cancer Res., 56, 2497–2500.

  • Borg A, Sandberg T, Nilsson K, Johannsson, Klinker M, Masback A, Westerdahl J, Olsson H and Ingvar C . (2000). J. Natl Cancer Inst., 92, 1260–1266.

  • Box NF, Duffy DL, Chen W, Stark M, Martin NG, Sturm RA and Hayward NK . (2001) Am. J. Hum. Genet., 69, 765–773.

  • Breitbart M, Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, Breitbart EW, Weekbecker J, Panizzon R, Bahmer F, Tilgen W, Guggenmoos-Holzmann I and Orfanos CE . (1997). Acta Derm. Venereol., 77, 374–378.

  • Brenner AV, Lubin JH, Calista D and Landi MT . (2002). Am. J. Epidemiol., 156, 353–362.

  • Buller OB, Geller AC, Santor M, Buller MK, Rosseel K, Hufford D, Benjes SL and Lew RA . (2002). Arch. Dermatol., 138, 771–774.

  • Bulliard J-L, Cox B . (2000). Int. J. Epidemiol., 29, 416–423.

  • Chaudru V, Chompret A, Avril MF, Bressac-de Paillerets B, French Hereditary Melanoma Study Group and Demenais F . (2001). Melanoma Res., 11(Suppl. 1), S143.

  • Ciotti P, Strewing JP, Mantelli M, Chompret A, Avril MF, Santi PL, Tucker MA, Scarra-Bianchi G, Paillerets BB and Goldstein AM . (2000). Am. J. Hum. Genet., 67, 311–319.

  • Clark Jr WH, Reimer RR, Greene MH, Ainsworth AM and Mastrangelo MJ . (1978). Arch. Dermatol., 114, 732–738.

  • Clark Jr WH and Tucker MA . (1998). Hum. Pathol., 29, 8–14.

  • Clemente C, Cochran AJ, Elder DE, Levene A, MacKie RM, Mihm MC, Rilke F, Cascinelli N, Fitzpatrick TB and Sober AJ . (1991). Hum. Pathol., 22, 313–319.

  • Cokkinides VE, Weinstock MA, O'Connell MC and Thun MJ . (2002). Pediatrics, 109, 1124–1130.

  • Darlington S, Siskind V, Green L and Green A . (2002). J. Am. Acad. Dermatol., 46, 715–722.

  • Davis KJ, Cokkinides VE, Weinstock MA, O'Connell MC and Wingo PA . (2002). Pediatrics, 110, 27–35.

  • Dwyer T, Prota G, Blizzard L, Ashbolt R and Vincensi MR . (2000). Melanoma Res., 10, 387–394.

  • Elwood JM and Jopson J . (1997). Int. J. Cancer, 73, 198–203.

  • English DR, Armstrong BK and Kricker A . (1998). Cancer Epidemiol. Biomarkers Prev., 7, 857–863.

  • Fears TR, Bird CC, Guerry D IV, Sagebiel RW, Gail MH, Elder DE, Halpern A, Holly EA, Hartge P and Tucker MA . (2002). Cancer Res., 62, 3992–3996.

  • Ford D, Bliss JM, Swerdlow AJ, Armstrong BK, Franceschi S, Green A, Holly EA, Mack T, MacKie RM, Osterlind A, Walter SD, Peto J and Easton DF . (1995). Int. J. Cancer, 62, 377–381.

  • Gallagher RP, Rivers JK, Lee TK, Bajdik CD, McLean DI and Coldman AJ . (2000). JAMA, 283, 2955–2960.

  • Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, Roser M, Weckbecker J, Panizzon R, Bahmer F, Tilgen W, Guggenmoos-Holzmann I and Orfanos CE . (1994a). J. Invest. Dermatol., 102, 695–699.

  • Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, Roser M, Weckbecker J, Panizzon R, Bahmer F, Tilgen W, Guggenmoos-Holzmann I and Orfanos CE . (1994b). J. Invest. Dermatol., 102, 700–705.

  • Geller AC, Colditz G, Oliveria S, Emmons K, Jorgersen C, Aweh GN and Frazier AL . (2002). Pediatrics, 109, 1009–1014.

  • Ghiorzo P, Ciotti P, Mantelli M, Heouaine A, Queirolo P, Rainero ML, Ferrari C, Santi PL, De Marchi R, Farris A, Ajmar F, Bruzzi P and Bianchi-Scarra G . (1999). Int. J. Cancer, 83, 441–448.

  • Giles GG, Armstrong BK, Burton RC, Staples MP and Thursfield VJ . (1996). BMJ, 312, 1121–1125.

  • Goldstein AM, Chidambaram A, Halpern A, Holly EA, Guerry IV D, Sagebiel R, Elder DE and Tucker MA . (2002). Melanoma Res., 12, 51–55.

  • Goldstein AM, Fraser MC, Struewing JP, Hussussian CJ, Ranade K, Zametkin DP, Fontaine LS, Organic SM, Dracopoli NC, Clark Jr WH and Tucker MA . (1995). N. Engl. J. Med., 333, 970–974.

  • Goldstein AM, Liu L, Shennan MG, Hogg D, Tucker MA and Struewing JP . (2001). Br. J. Cancer, 85, 527–530.

  • Goldstein AM, Martinez M, Tucker MA and Demenais F . (2000a). Cancer Epidemiol. Biomarkers Prev., 9, 889–894.

  • Goldstein AM, Struewing JP, Chidambaram A, Fraser MC and Tucker MA . (2000b). J. Natl. Cancer Inst., 92, 1006–1010.

  • Gruis NA, Sandkuijl LA, van der Velden PA, Bergman W and Frants RR . (1995). Melanoma Res., 5, 169–177.

  • Halpern AC, Guerry D IV, Elder DE, Clark Jr WH, Synnestvedt M, Norman S and Ayerle R . (1991). Arch. Dermatol., 127, 995–999.

  • Halpern AC, Guerry D IV, Elder DE, Trock B, Synnestvedt M and Humphreys T . (1993a). J. Am. Acad. Dermatol., 29, 51–57.

  • Halpern AC, Guerry D IV, Elder DE, Trock B and Synnestvedt M . (1993b). J. Invest. Dermatol., 100, S346–S349.

  • Harrison SL, Buettner PG and MacLennan R . (1999). Arch. Dermatol., 135, 47–52.

  • Harrison SL, MacLennan R, Speare R and Wronski I . (1994). Lancet, 344, 529–532.

  • Hartge P, Holly EA, Halpern A, Sagebiel R, Guerry D, Elder D, Clark W, Hanson L, Harrison C, Tarone R and Tucker MA . (1995). Cancer Epidemiol. Biomarkers Prev., 4, 37–40.

  • Hashemi J, Bendahl PO, Sandberg T, Platz A, Linder S, Stierner U, Olsson H, Ingvar C, Hansson J and Borg A . (2001). Genes, Chromosomes, Cancer, 31, 107–116.

  • Hashemi J, Linder S, Platz A and Hansson J . (1999). Melanoma Res., 9, 21–30.

  • Holly EA, Weiss NS and Liff JM . (1983). J. Natl. Cancer Inst., 70, 827–831.

  • Holly EA, Kelly JW, Shpall SN and Chiu S-H . (1987). J. Am. Acad. Dermatol., 17, 459–468.

  • Huncharek M and Kupelnick B . (2002). Am. J. Public Health, 92, 1173–1177.

  • Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark JR WC, Tucker MA and Dracopoli NC . (1994). Nat. Genet., 8, 15–21.

  • Jemal A, Devesa SS, Fears TR and Hartge P . (2000). J. Natl. Cancer Inst., 92, 811–818.

  • Jemal A, Devesa SS, Hartge P and Tucker MA . (2001). J. Natl. Cancer Inst., 93, 678–683.

  • Jemal A, Thomas A, Murray T and Thun M . (2002). CA Cancer J. Clin., 52, 23–47.

  • Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weavex-Feldhaus J, McClure AM, Aitken JF, Anderson DE, Bergman W, Frants R, Goldgar DE, Green A, MacLennan R, Martin NG, Meyer LJ, Youl P, Zone JJ, Scolnick MH and Cannon-Albright LA . (1994). Genet., 22–32.

  • Kanetsky PA, Holmes R, Walker A, Najarian D, Swoyer J, Guerry D, Halpern A and Rebbeck TR . (2001). Cancer Epidemiol. Biomarkers Prev., 10, 509–513.

  • Karagas MR, Stukel TA, Dykes J, Miglionico J, Greene MA, Carey M, Armstrong B, Elwood JM, Gallager RP, Green A, Holly EA, Kirkpatrick CS, Mack T, Osterlind A, Rosso S and Swerdlow AJ . (2002). Br. J. Cancer, 86, 1085–1092.

  • Karlsson P, Stenberg B and Rosdahl I . (2000). Acta Derm. Venereol., 80, 335–339.

  • Kefford R, Newton Bishop J, Bergman W and Tucker M . (1999). J. Clin. Oncol., 17, 3245–3251.

  • Kefford R, Newton Bishop J, Tucker M, Bressac-de Paillerets B, Bianchi-Scarra G, Bergman W, Goldstein A, Puig S, MacKie R, Elder D, Hansson J, Hayward N, Hogg D, Olsson H and for the Melanoma Genetics Consortium. Lancet. (2002). Oncology, 3, 653–654.

  • Kelly JW, Rivers JK, MacLennan R, Harrison S, Lewis AE and Tate BJ . (1994). J. Am. Acad. Dermatol., 30, 40–48.

  • Kelly JW, Yeatman JM, Regalia C, Mason G and Henham AP . (1997). Med. J. Aust., 167, 191–194.

  • Kopf AW, Hellman LJ, Rogers GS, Gross DF, Rigel DS, Friedman RJ, Levenstein M, Brown J, Golomb FM and Roses DF . (1986). JAMA, 256, 1915–1919.

  • Kwan T, Belke TW and Enta T . (2000). J. Cut. Med. Surg., 4, 58–62.

  • Lamberg L . (2002). JAMA, 287, 2201.

  • Landi MT, Baccarelli A, Calista D, Pesatori A, Fears T, Tucker MA and Landi G . (2001). Br. J. Cancer, 85, 1304–1310.

  • Landi MT, Baccarelli A, Tarone RE, Pesatori A, Tucker MA, Hedayati M and Grossman L . (2002). J. Natl. Cancer Inst., 94, 94–101.

  • Landi MT, Calista D, Landi G, Bernucci I, Bertazzi PA, Clark Jr WH, Goldstein AM and Tucker MA . (1999). Arch. Dermatol., 135, 1554–1555.

  • Lee JS, Holly E, Halpern A, Sagebiel R, Guerry D, Elder D, Clark W, Tucker M and Hartge P . (1998). Proceedings of the 1998 ASCO Annual Meeting, Los Angeles, USA, vol. 17, p. 514a.

  • Lucci A, Citro HW and Wilson L . (2001). J. Surg. Res., 97, 179–183.

  • Lynch HT, Brand RE, Hogg D, Deters CA, Fusaro RM, Lynch JF, Liu L, Knezetic J, Lassam NJ, Goggins M and Kern S . (2002). Cancer, 94, 84–96.

  • Lynch HT, Frichot III BC and Lynch JF . (1978). J. Med. Genet., 15, 352–356.

  • MacGregor B, Pfitzner J, Zhu G, Grace M, Eldridge A, Pearson J, Mayne C, Aitken JF, Green AC and Martin NC . (1999). Genet. Epidemiol., 16, 40–53.

  • MacKie RM . (1982). Br. J. Dermatol., 107, 621–629.

  • MacKie RM, Bray CA, Hole DJ, Morris A, Nicholson M, Evans A, Doherty V, Vestey J and for the Scottish Melanoma Group. (2002). Lancet, 360, 587–591.

  • MacKie RM, Freudenberger T and Aitchison TC . (1989). Lancet, 2, 487–490.

  • Mansson-Brahme E, Johansson H, Larsson O, Rutqvist LE and Ringborg U . (2002). Acta Oncol., 41, 138–146.

  • Mantelli M, Barile M, Ciotti P, Ghiorzo P, Lantieri F, Pastorino L, Catricala C, Della Torre G, Folco U, Grammatico P, Padovani L, Pasini B, Rovini D, Queirolo P, Rainero ML, Santi PL, Sertoli RM, Goldstein AM, Societa Italiana Dermatologia e Venerologia, Gruppo Italiano Studi Epidemiologici in Dermatologia, and Bianchi-Scarra G . (2002). Am. J. Med. Genet., 107, 214–221.

  • Marks R . (2002). Recent Results Cancer Res., 160, 113–121.

  • Marrett LD, Nguyen HL and Armstrong BK . (2001). Int. J. Cancer, 92, 457–462.

  • Milne E, Johnston R, Cross D, Giles-Corti B and English DR . (2002). Am. J. Epidemiol., 155, 739–745.

  • Newton-Bishop JA, Bataille V, Pinney D and Bishop DT . (1994). Melanoma Res., 4, 199–206.

  • Newton-Bishop JA, Wachsmuth RC, Harland M, Bataille V, Pinney E, Mack P, Baglietto, L, Cuzick J and Bishop DT . (2000). J. Invest. Dermatol., 114, 28–33.

  • Nordlund JJ, Kirkwood J, Forget BM, Scheibner A, Albert DA, Lerner E and Milton GW . (1985). Cancer Res., 45, 1855–1861.

  • Osterlind A, Tucker MA, Hou-Jensen K, Stone BJ, Engholm G and Jensen OM . (1988a). Int. J. Cancer, 42, 200–206.

  • Osterlind A, Tucker MA, Stone BJ and Jensen OM . (1988b). Int. J. Cancer, 42, 821–824.

  • Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, Hayward NK, Martin MG and Sturm RA . (2000). Am. J. Hum. Genet., 66, 176–186.

  • Pfalberg A, Kolmel K-F and Gefeller O for the FEBIM Study Group. (2001). Br. J. Dermatol., 144, 471–475.

  • Platz A, Hansson J, Mansson-Brahme E, Lagerlof B, Linder S, Lunqvist E, Sevigny P, Inganas M and Ringborg U . (1997). J. Natl. Cancer Inst., 89, 697–702.

  • Pollock PM, Spurr N, Bishop T, Newton-Bishop J, Gruis N, Goldstein AM, Tucker MA, Foulkes W, Barnhill R, Haber D, Fountain J and Hayward NK . (1998). Hum. Mutat., 11, 424–431.

  • Puig S, Ruiz A, Castel T, Volpini V, Malvehy J, Cadellach F, Lynch M, Mascaron JM and Estivill X . (1997). Hum. Genet., 101, 359–364.

  • Randerson-Moor JA, Harland M, Williams S, Cuthbert-Heavens D, Sheridan E, Aveyard J, Sibley K, Whitaker L, Knowles M, Newton-Bishop J and Bishop DT . (2000). Hum. Mol. Genet., 10, 55–62.

  • Rigel DS, Rivers JK, Kopf AW, Friedman RJ, Vinokur AF, Heilman ER and Levenstein M . (1989). Cancer, 63, 386–389.

  • Rizos H, Puig S, Badenas C, Malveny J, Darmanian AP, Jimenez L, Mila M and Kefford RF . (2001). Oncogene, 20, 5543–5547.

  • Ruiz A, Puig S, Malvehy J, Lazaro C, Lynch M, Gimenez-Arnau AM, Puig L, Snchez-Conejo J, Estivill X and Castel T . (1999). J. Med. Genet., 36, 490–493.

  • Saraiya M, Hall HI and Uhler RJ . (2002). Am. J. Prev. Med., 23, 91–97.

  • Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Lyonnet D, the French Familial Melanoma Study Group, Benard J and Bressac-Paillerets B . (1998). Hum. Mol. Genet., 7, 209–216.

  • Stierner U, Augustsson A, Rosdahl I and Suurkula M . (1991). Melanoma Res., 1, 367–375.

  • Surveillance, Epidemiology and End Results. (2003). http://seer.cancer.gov.

  • Tucker MA, Fraser MC, Goldstein AM, Struewing JP, King MA, Crawford JT, Chiazze EA, Zametkin DP, Fontaine LS and Clark Jr WH . (2002). Cancer, 94, 3192–3209.

  • Tucker MA, Halpern A, Holly EA, Hartge P, Elder DE, Sagebiel RW, Guerry DIV and Clark Jr WH . (1997). JAMA, 277, 1439–1404.

  • van der Velden PA, Sandkuijl LA, Bergman W, Pavel S, van Mourik L, Frants RR and Gruis N . (2001) Am. J. Hum. Genet., 69, 774–779.

  • Vasen HF, Gruis NA, Frants RR, van der Velden PA, Hille ET and Bergman W . (2000). Int. J. Cancer, 87, 809–811.

  • Wachsmuth RC, Gaut RM, Barrett JH, Saunders CL, Randerson-Moor, JA, Eldridge A, Martin NG, Bishop DT and Newton-Bishop JA . (2001). J. Invest. Dermatol., 117, 348–352.

  • Weinstock MA, Barnhill RL, Rhodes AR, Brodsky GL and Dysplastic Nevus Panel. (1997). Arch. Dermatol., 133, 953–958.

  • Weinstock MA, Rossi JS, Redding CA, Maddock JE and Cottrill SD . (2000). Ann Behav. Med., 22, 286–293.

  • White E, Kirkpatrick CS and Lee JAH . (1994). Am. J. Epidemiol., 139, 857–868.

  • Whiteman DC, Whiteman CA and Green AC . (2001). Cancer Causes Control, 12, 69–82.

  • Youl P, Aitken J, Hayward N, Hogg D, Liu L, Lassam N, Martin N and Green A . (2002). Int. J. Cancer, 98, 92–98.

  • Zanetti R, Prota G, Napolitano A, Martinez C, Sancho-Garnier H, Osterlind A, Sacerdole C and Rosso S . (2001). Melanoma Res., 11, 551–557.

  • Zhu G, Duffy DL, Eldridge A, Grace M, Mayne C, O'Gorman L, Aitken JF, Neale AM, Hayward NK, Green AC and Martin NG . (1999). Am. J. Hum. Genet., 65, 483–492.

  • Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward M and Dracopoli NC . (1996). Nat. Genet., 12, 97–99.

Download references

Author information

Authors and Affiliations

  1. Genetic Epidemiology Branch, DCEG, NCI, Executive Plaza South 7122, 6120 Executive Blvd, Rockville, 20892-7236, MD, USA

    Margaret A Tucker

  2. Genetic Epidemiology Branch DCEG, NCI, Executive Plaza South 7004, Rockville, 20892-7236, MD, USA

    Alisa M Goldstein

Authors
  1. Margaret A Tucker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alisa M Goldstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Margaret A Tucker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tucker, M., Goldstein, A. Melanoma etiology: where are we?. Oncogene 22, 3042–3052 (2003). https://doi.org/10.1038/sj.onc.1206444

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206444

Keywords

This article is cited by

Search

Advanced search

Quick links